Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

China Clears HIV Oral Antiviral For COVID, Vows More Drug Approvals

26 Jul 2022

• By Brian Yang

Doctor with Covid pill — CHINA APPROVES AZVUDINE FOR COVID-19, VOWS MORE DRUG NODS • Source: Shutterstock

Related Content

Japan Again Postpones Approval Of Shionogi COVID Antiviral

21 Jul 2022

Brii Launches COVID Antibody As Shanghai Tightens Restrictions

14 Jul 2022

Related Companies

Pfizer Inc.

Brii Biosciences

Junshi Biosciences/Immorna Joint Venture

Shionogi & Co. Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Moderna, Inc.

BioNTech SE

Additional Topics

China Asia Pacific Approvals Coronavirus COVID-19 Policy BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.